Search

Search Constraints

You searched for: Is Part Of MAbs. Volume 11:Issue 8(2019)

Search Results

2. Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. Issue 8 (17th November 2019)

3. Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. Issue 8 (17th November 2019)

4. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes. Issue 8 (17th November 2019)

7. DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity. Issue 8 (17th November 2019)

8. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. Issue 8 (17th November 2019)

10. Identification and characterization of an IgG sequence variant with an 11 kDa heavy chain C-terminal extension using a combination of mass spectrometry and high-throughput sequencing analysis. Issue 8 (17th November 2019)